AudioCure Pharma

AudioCure Pharma GmbH is a pharmaceutical R&D company focused on hearing disorders. The company was founded by Professor Hans Rommelspacher, the former director of the Department of Clinical Neurobiology at the Charité University Psychiatric Clinic in Berlin. He has extensive experience in research on neuroprotection and treatments for neurodegenerative diseases. The Chief Operating Officer, Dr. Reimar Schlingensiepen, is a serial entrepreneur and manager of biopharmaceutical companies. He has initiated and led numerous deals in the high-tech industry. AudioCure's team of experts is dedicated to preclinical research and clinical development of novel drug therapies for inner ear diseases. AudioCure Pharma's lead candidate is a small molecule compound used for treating acute and chronic hearing disorders through local regenerative therapy of damaged nerve cells in the inner ear.